首页> 外文期刊>Infection and immunity >Effect of Bronchoalveolar Lavage Fluid from Pneumocystis carinii- Infected Hosts on Phagocytic Activity of Alveolar Macrophages
【24h】

Effect of Bronchoalveolar Lavage Fluid from Pneumocystis carinii- Infected Hosts on Phagocytic Activity of Alveolar Macrophages

机译:卡氏肺孢子虫感染宿主的支气管肺泡灌洗液对肺泡巨噬细胞吞噬活性的影响

获取原文
           

摘要

Alveolar macrophages from Pneumocystis carinii-infected rats are defective in phagocytosis. To investigate whether this defect is due to a certain factor present in P. carinii-infected lungs, alveolar macrophages from uninfected rats were incubated with bronchoalveolar lavage (BAL) fluid samples from P. carinii-infected rats. Alveolar macrophages treated with these BAL fluid samples became defective in phagocytosis but remained normal when treated with BAL fluid samples from noninfected or Toxoplasma gondii-infected rats. The suppressive activity of the BAL fluid samples from P. carinii-infected rats on phagocytosis was retained when the BAL fluid samples were passed through a filter with a pore size of 0.45 μm but was lost when the BAL fluid samples were digested with proteases such as trypsin, pepsin, papain, or endopeptidase Gly-C. Lipid fractions of these BAL fluid samples had no suppressive activity on phagocytosis. The suppressive activity of these BAL fluid samples was also lost when they were incubated with concanavalin A-agarose beads, suggesting that the inhibitor is a glycoprotein. The inhibitor was estimated to be larger than 100,000 Da by exclusion filtration. After binding to the concanavalin A-agarose beads, the inhibitor in BAL fluid samples and P. carinii lysate could be eluted with 200 mM methylmannose. Treatment of both the crude BAL fluid samples and P. carinii lysate and the 200 mM methylmannose eluate with antibody against the major surface glycoprotein of P. carinii eliminated their suppressive activity. These results suggest that the factor capable of suppressing the phagocytic activity of alveolar macrophages is P. carinii major surface glycoprotein or one or more of its derivatives.
机译:卡因肺孢子虫感染的大鼠的肺泡巨噬细胞在吞噬作用方面存在缺陷。调查此缺陷是否归因于 P中存在的某个因素。感染卡里氏肺的肺中,将未感染大鼠的肺泡巨噬细胞与 P的支气管肺泡灌洗液(BAL)孵育。卡林氏感染的大鼠。用这些BAL液样品处理的肺泡巨噬细胞吞噬功能有缺陷,但用未感染或弓形虫感染的大鼠的BAL液样品处理时,它们保持正常。来自 P的BAL流体样品的抑制活性。当BAL液体样品通过孔径为0.45μm的过滤器时,被卡里氏菌感染的大鼠保留了吞噬作用,但当BAL液体样品用蛋白酶(例如胰蛋白酶,胃蛋白酶,木瓜蛋白酶或内肽酶Gly-C。这些BAL液样品中的脂质级分对吞噬作用没有抑制活性。这些BAL液体样品与伴刀豆球蛋白A-琼脂糖珠一起孵育时,其抑制活性也丧失,表明该抑制剂是糖蛋白。通过排除过滤估计该抑制剂大于100,000 Da。结合伴刀豆球蛋白A-琼脂糖珠后,BAL液体样品和 P中的抑制剂。卡林氏裂解液可用200 mM甲基甘露糖洗脱。处理BAL原油样品和 P。卡林氏菌裂解液和200 mM甲基甘露糖洗脱液,具有针对 P主要表面糖蛋白的抗体。 Carinii 消除了其抑制活性。这些结果表明,能够抑制肺泡巨噬细胞吞噬活性的因子是 P。卡林氏主要表面糖蛋白或其一种或多种衍生物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号